Head of Orphan Drugs
European Medicines Agency
Kristina Larsson is the Head of the Orphan Office at EMA and the scientific lead of the Committee of Orphan Medicinal Products (COMP), a position she has held since July 2014. Prior to this she spent 8 years as a scientific officer in the scientific advice team of the EMA, mostly focusing on oncology, inborn errors of metabolism and biosimilar monoclonal antibodies. Before joining the agency she worked three years in clinical research for AstraZeneca in Mölndal, Sweden. Kristina has a master of Medicine in Pharmaceutical Bioscience from the University of Gothenburg.
Disclosure information not submitted.
Tuesday, May 7, 2024
08:30 – 09:30 CEST
International Regulatory Frameworks to Accelerate Orphan Drug Registrations
Wednesday, May 8, 2024
14:00 – 15:00 CEST
Orphan Devices: How to Obtain Orphan or Pediatric Medical Device Approval
Wednesday, May 8, 2024
15:40 – 16:40 CEST